An intra- & inter-provincial analysis of the Fair Pharmacare policy in British Columbia

In the wake of several recommendations for a national approach to pharmacare, the provincial government of British Columbia made the most significant changes to its PharmaCare program in over two decades. On May 1, 2003, two major PharmaCare plans - the seniors' plan and the universal plan -...

Full description

Bibliographic Details
Main Author: Coombes, Megan Eileen
Language:English
Published: 2009
Online Access:http://hdl.handle.net/2429/15461
id ndltd-LACETR-oai-collectionscanada.gc.ca-BVAU.2429-15461
record_format oai_dc
spelling ndltd-LACETR-oai-collectionscanada.gc.ca-BVAU.2429-154612014-03-14T15:48:18Z An intra- & inter-provincial analysis of the Fair Pharmacare policy in British Columbia Coombes, Megan Eileen In the wake of several recommendations for a national approach to pharmacare, the provincial government of British Columbia made the most significant changes to its PharmaCare program in over two decades. On May 1, 2003, two major PharmaCare plans - the seniors' plan and the universal plan - were combined into a single income-tested plan known as "Fair PharmaCare". Through semi-structured interviews with seventeen policy makers I gathered insights about the fairness principles underlying this policy change. Based on the fairness objectives described by these participants, I aimed to evaluate whether the new pharmacare model would achieve its goals. Through simulations I estimated the distribution of financial burdens that would occur under the pre- and post-pharmacare models by applying the cost-sharing rules to hypothetical family types. The family compositions, income levels, and drug expenditures were selected to represent distributions of these variables drawn from real-world data sources—including the 2001 Census and provincial drug expenditure reports. Comparing the Fair PharmaCare model to the other nine provincial pharmacare models across Canada extended the analysis. Contrasted against the old pharmacare model in BC, Fair PharmaCare better protects against extremely high drug costs and better targets subsidies at low-income households. However, this is achieved at the expense of seniors predominantly, who will receive much less coverage for modest drug costs, than in the past. Compared to other provincial pharmacare models in Canada, Fair PharmaCare effectively protects against catastrophic drug costs. Universal models that employ income based maximum contribution limits best protect against catastrophic drug costs, while less comprehensive models in Atlantic Canada, and premium-based models in Quebec and Alberta, provide poorer protection. 2009-11-21T20:39:08Z 2009-11-21T20:39:08Z 2004 2009-11-21T20:39:08Z 2004-11 Electronic Thesis or Dissertation http://hdl.handle.net/2429/15461 eng UBC Retrospective Theses Digitization Project [http://www.library.ubc.ca/archives/retro_theses/]
collection NDLTD
language English
sources NDLTD
description In the wake of several recommendations for a national approach to pharmacare, the provincial government of British Columbia made the most significant changes to its PharmaCare program in over two decades. On May 1, 2003, two major PharmaCare plans - the seniors' plan and the universal plan - were combined into a single income-tested plan known as "Fair PharmaCare". Through semi-structured interviews with seventeen policy makers I gathered insights about the fairness principles underlying this policy change. Based on the fairness objectives described by these participants, I aimed to evaluate whether the new pharmacare model would achieve its goals. Through simulations I estimated the distribution of financial burdens that would occur under the pre- and post-pharmacare models by applying the cost-sharing rules to hypothetical family types. The family compositions, income levels, and drug expenditures were selected to represent distributions of these variables drawn from real-world data sources—including the 2001 Census and provincial drug expenditure reports. Comparing the Fair PharmaCare model to the other nine provincial pharmacare models across Canada extended the analysis. Contrasted against the old pharmacare model in BC, Fair PharmaCare better protects against extremely high drug costs and better targets subsidies at low-income households. However, this is achieved at the expense of seniors predominantly, who will receive much less coverage for modest drug costs, than in the past. Compared to other provincial pharmacare models in Canada, Fair PharmaCare effectively protects against catastrophic drug costs. Universal models that employ income based maximum contribution limits best protect against catastrophic drug costs, while less comprehensive models in Atlantic Canada, and premium-based models in Quebec and Alberta, provide poorer protection.
author Coombes, Megan Eileen
spellingShingle Coombes, Megan Eileen
An intra- & inter-provincial analysis of the Fair Pharmacare policy in British Columbia
author_facet Coombes, Megan Eileen
author_sort Coombes, Megan Eileen
title An intra- & inter-provincial analysis of the Fair Pharmacare policy in British Columbia
title_short An intra- & inter-provincial analysis of the Fair Pharmacare policy in British Columbia
title_full An intra- & inter-provincial analysis of the Fair Pharmacare policy in British Columbia
title_fullStr An intra- & inter-provincial analysis of the Fair Pharmacare policy in British Columbia
title_full_unstemmed An intra- & inter-provincial analysis of the Fair Pharmacare policy in British Columbia
title_sort intra- & inter-provincial analysis of the fair pharmacare policy in british columbia
publishDate 2009
url http://hdl.handle.net/2429/15461
work_keys_str_mv AT coombesmeganeileen anintrainterprovincialanalysisofthefairpharmacarepolicyinbritishcolumbia
AT coombesmeganeileen intrainterprovincialanalysisofthefairpharmacarepolicyinbritishcolumbia
_version_ 1716653299494551552